FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

2016 MS Forum to Focus on Distinctions in Disease Forms



























Texas researcher to open ACTRIMS with talk on boundaries between relapsing and progressive MS

Dr. Jerry S. Wolinsky of the University of Texas in Houston, will give the first Kenneth P. Johnson Memorial Lecture at the opening day of the Americas Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016 in New Orleans, focusing on distinctions between relapsing and progressive disease forms.

ACTRIMS is an American and Canadian community of leaders focused on multiple sclerosis research, treatment, and education. The forum, entitled Progressive MS: From Bench to Bedside and Back, is the first, standalone event organized by the committee for North American clinicians and researchers working with MS. It is set for Feb. 18–20, 2016, at the Hyatt Regency.

Dr. Wolinsky will discuss the boundaries between relapsing and progressive MS, a distinction he believes important to finding better therapeutic strategies.

“Recognition of the different forms of multiple sclerosis dates back to the earliest descriptions of the disease,” Dr. Wolinsky said in a news release. “By distinguishing between relapsing and progressive MS — in particular, the transition from early relapsing to secondary progressive MS — we hope to better understand and manage the progressive phase disease.”

Progressive MS is characterized by a gradual, steady progression of disability, leading to impaired vision and walking, pain, fatigue, incontinence, and cognitive changes. Patients with secondary progressive MS (SPMS) initially experience a relapsing-remitting MS phase (RRMS) of neurological dysfunction that evolves into a secondary progressive disease which,  typically, is less responsive to treatment.

A clear boundary between early RRMS and the progression to SPMS has not been established. Researchers have proposed that such a boundary might be seen by unraveling how relapses contribute to progression through a careful analysis of clinical attack-free patients with a “pure” form of progressive MS, or primary progressive MS (PPMS), a progressive form without distinct relapses or sudden attacks.

Dr. Wolinsky will focus on registration quality trials that may provide more insights into MS progression and how to manage the progressive phase of the disease, taking into account data obtained from smaller cohorts.

The Kenneth P. Johnson Memorial Lecture honors Dr. Johnson, who led the efforts to found ACTRIMS in 1996, by offering ACTRIMS audiences the opportunity to hear a prestigious researcher or clinician on his/her accomplishments and contributions to the MS field.

For more information about ACTRIMS Forum 2016, please visit the link.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News